Create Medic Valuation
Is 5187 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Unter dem Marktwert
Deutlich unter dem Marktwert
Price-To-Earnings gegen Gleichaltrige
Price-To-Earnings gegen Industrie
PM vs. Fair Ratio
Analysten-Prognose
Share Price vs Fair Value
What is the Fair Price of 5187 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Unter dem Marktwert: 5187 (¥910) wird über unserer Schätzung des Fair Value (¥665.82) gehandelt.
Deutlich unter dem Marktwert: 5187 über unserer Schätzung des beizulegenden Zeitwerts gehandelt wird.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 5187?
Other financial metrics that can be useful for relative valuation.
What is 5187's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | JP¥9.16b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.4x |
Enterprise Value/EBITDA | 4x |
PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does 5187's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 28.3x | ||
7963 Koken | 11.4x | n/a | JP¥8.0b |
7702 JMSLtd | 62.8x | n/a | JP¥13.0b |
3604 Kawamoto | 10.1x | n/a | JP¥4.7b |
7743 SEEDLtd | 28.9x | n/a | JP¥19.0b |
5187 Create Medic | 59.9x | n/a | JP¥9.2b |
Price-To-Earnings gegen Gleichaltrige: 5187 ist auf der Grundlage des Price-To-Sales Verhältnisses (0.7x) im Vergleich zum Durchschnitt der Vergleichsgruppe (0.4x) teuer.
Price to Earnings Ratio vs Industry
How does 5187's PE Ratio compare vs other companies in the JP Medical Equipment Industry?
Price-To-Earnings gegen Industrie: 5187 ist teuer, wenn man sein Price-To-Earnings Verhältnis (56.6x) mit dem JP Medical Equipment Branchendurchschnitt (16.2x) vergleicht.
Price to Earnings Ratio vs Fair Ratio
What is 5187's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 59.9x |
Fair PE Ratio | n/a |
PM vs. Fair Ratio: Unzureichende Daten zur Berechnung der Price-To-Sales Fair Ratio von 5187 für die Bewertungsanalyse.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analysten-Prognose: Unzureichende Daten für eine Preisprognose.